Emile R. Chimusa

Prof. Dr. Emile R. Chimusa

Northumbria University, Newcastle upon Tyne, UK
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2019 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
FAFrancis E Agamah
Francis E Agamah
GMGaston Kuzamunu Mazandu
Gaston Kuzamunu Mazandu
RHRadia Hassan
Radia Hassan
CBChristian D Bope
Christian D Bope
NTNicholas Ekow Thomford
Nicholas Ekow Thomford
Emile R. ChimusaEmile R. Chimusa
Emile R. Chimusa
Drug-like compounds are most of the time denied approval and use owing to the unexpected clinical side effects and cross-reactivity observed during clinical trials. These unexpected outcomes resulting in significant increase in attrition rate centralizes on the selected drug targets. These targets may be disease candidate proteins or genes, biological pathways, disease-associated microRNAs, disease-related biomarkers, abnormal molecular phenotypes, crucial nodes of biological network or molecular functions. This is generally linked to several factors, including incomplete knowledge on the drug targets and unpredicted pharmacokinetic expressions upon target interaction or off-target effects. A method used to identify targets, especially for polygenic diseases, is essential and constitutes a major bottleneck in drug development with the fundamental stage being the identification and validation of drug targets of interest for further downstream processes. Thus, various computational methods have been developed to complement experimental approaches in drug discovery. Here, we present an overview of various computational methods and tools applied in predicting or validating drug targets and drug-like molecules. We provide an overview on their advantages and compare these methods to identify effective methods which likely lead to optimal results. We also explore major sources of drug failure considering the challenges and opportunities involved. This review might guide researchers on selecting the most efficient approach or technique during the computational drug discovery process.

20 September 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
Emile R. ChimusaEmile R. Chimusa
Emile R. Chimusa
NZNoah Zaitlen
Noah Zaitlen
MDMichelle Daya
Michelle Daya
MMMarlo Moller
Marlo Moller
PHPaul D. van Helden
Paul D. van Helden
EHEileen G. Hoal
Eileen G. Hoal
The worldwide burden of tuberculosis (TB) remains an enormous problem, and is particularly severe in the admixed South African Coloured (SAC) population residing in the Western Cape. Despite evidence from twin studies suggesting a strong genetic component to TB resistance, only a few loci have been identified to date. In this work, we conduct a genome-wide association study (GWAS), meta-analysis and trans-ethnic fine mapping to attempt the replication of previously identified TB susceptibility loci. Our GWAS results confirm the WT1 chr11 susceptibility locus (rs2057178: odds ratio = 0.62, P = 2.71e−06) previously identified by Thye et al., but fail to replicate previously identified polymorphisms in the TLR8 gene and locus 18q11.2. Our study demonstrates that the genetic contribution to TB risk varies between continental populations, and illustrates the value of including admixed populations in studies of TB risk and other complex phenotypes. Our evaluation of local ancestry based on the real and simulated data demonstrates that case-only admixture mapping is currently impractical in multi-way admixed populations, such as the SAC, due to spurious deviations in average local ancestry generated by current local ancestry inference methods. This study provides insights into identifying disease genes and ancestry-specific disease risk in multi-way admixed populations.

14 November 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
FAFrancis E. Agamah
Francis E. Agamah
JBJumamurat R. Bayjanov
Jumamurat R. Bayjanov
ANAnna Niehues
Anna Niehues
KNKelechi F. Njoku
Kelechi F. Njoku
MSMichelle Skelton
Michelle Skelton
PHPeter A. C. 'T Hoen
Peter A. C. 'T Hoen
Advances in omics technologies allow for holistic studies into biological systems. These studies rely on integrative data analysis techniques to obtain a comprehensive view of the dynamics of cellular processes, and molecular mechanisms. Network-based integrative approaches have revolutionized multi-omics analysis by providing the framework to represent interactions between multiple different omics-layers in a graph, which may faithfully reflect the molecular wiring in a cell. Here we review network-based multi-omics/multi-modal integrative analytical approaches. We classify these approaches according to the type of omics data supported, the methods and/or algorithms implemented, their node and/or edge weighting components, and their ability to identify key nodes and subnetworks. We show how these approaches can be used to identify biomarkers, disease subtypes, crosstalk, causality, and molecular drivers of physiological and pathological mechanisms. We provide insight into the most appropriate methods and tools for research questions as showcased around the aetiology and treatment of COVID-19 that can be informed by multi-omics data integration. We conclude with an overview of challenges associated with multi-omics network-based analysis, such as reproducibility, heterogeneity, (biological) interpretability of the results, and we highlight some future directions for network-based integration.

12 December 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAnanyo Choudhury
Ananyo Choudhury
MRMichèle Ramsay
Michèle Ramsay
SHScott Hazelhurst
Scott Hazelhurst
SAShaun Aron
Shaun Aron
SBSoraya Bardien
Soraya Bardien
Michael Sean PepperMichael Sean Pepper
Michael Sean Pepper
The Southern African Human Genome Programme is a national initiative that aspires to unlock the unique genetic character of southern African populations for a better understanding of human genetic diversity. In this pilot study the Southern African Human Genome Programme characterizes the genomes of 24 individuals (8 Coloured and 16 black southeastern Bantu-speakers) using deep whole-genome sequencing. A total of ~16 million unique variants are identified. Despite the shallow time depth since divergence between the two main southeastern Bantu-speaking groups (Nguni and Sotho-Tswana), principal component analysis and structure analysis reveal significant (p < 10−6) differentiation, and FSTanalysis identifies regions with high divergence. The Coloured individuals show evidence of varying proportions of admixture with Khoesan, Bantu-speakers, Europeans, and populations from the Indian sub-continent. Whole-genome sequencing data reveal extensive genomic diversity, increasing our understanding of the complex and region-specific history of African populations and highlighting its potential impact on biomedical research and genetic susceptibility to disease.

22 January 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
DADenis Awany
Denis Awany
IAImane Allali
Imane Allali
SDShareefa Dalvie
Shareefa Dalvie
SHSian Hemmings
Sian Hemmings
KMKilaza S. Mwaikono
Kilaza S. Mwaikono
Emile R. ChimusaEmile R. Chimusa
Emile R. Chimusa
The involvement of the microbiome in health and disease is well established. Microbiome genome-wide association studies (mGWAS) are used to elucidate the interaction of host genetic variation with the microbiome. The emergence of this relatively new field has been facilitated by the advent of next generation sequencing technologies that enable the investigation of the complex interaction between host genetics and microbial communities. In this paper, we review recent studies investigating host–microbiome interactions using mGWAS. Additionally, we highlight the marked disparity in the sampling population of mGWAS carried out to date and draw attention to the critical need for inclusion of diverse populations.

20 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMichelle Daya
Michelle Daya
LMLize Van Der Merwe
Lize Van Der Merwe
UGUshma Galal
Ushma Galal
MMMarlo Moller
Marlo Moller
MSMuneeb Salie
Muneeb Salie
EHEileen Hoal
Eileen Hoal
Admixture is a well known confounder in genetic association studies. If genome-wide data is not available, as would be the case for candidate gene studies, ancestry informative markers (AIMs) are required in order to adjust for admixture. The predominant population group in the Western Cape, South Africa, is the admixed group known as the South African Coloured (SAC). A small set of AIMs that is optimized to distinguish between the five source populations of this population (African San, African non-San, European, South Asian, and East Asian) will enable researchers to cost-effectively reduce false-positive findings resulting from ignoring admixture in genetic association studies of the population. Using genome-wide data to find SNPs with large allele frequency differences between the source populations of the SAC, as quantified by Rosenberg et. al's -statistic, we developed a panel of AIMs by experimenting with various selection strategies. Subsets of different sizes were evaluated by measuring the correlation between ancestry proportions estimated by each AIM subset with ancestry proportions estimated using genome-wide data. We show that a panel of 96 AIMs can be used to assess ancestry proportions and to adjust for the confounding effect of the complex five-way admixture that occurred in the South African Coloured population.